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Abstract
Laboratory surveillance systems for salmonellosis should ideally be based on the rapid serotyping and subtyping of isolates.
However, current typing methods are limited in both speed and precision. Using 783 strains and isolates belonging to 130
serotypes, we show here that a new family of DNA repeats named CRISPR (clustered regularly interspaced short palindromic
repeats) is highly polymorphic in Salmonella. We found that CRISPR polymorphism was strongly correlated with both
serotype and multilocus sequence type. Furthermore, spacer microevolution discriminated between subtypes within
prevalent serotypes, making it possible to carry out typing and subtyping in a single step. We developed a high-throughput
subtyping assay for the most prevalent serotype, Typhimurium. An open web-accessible database was set up, providing a
serotype/spacer dictionary and an international tool for strain tracking based on this innovative, powerful typing and
subtyping tool.
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Introduction
Salmonellosis is one of the most common causes of food-borne
diarrheal disease worldwide. Most infections are zoonotic and are
transmitted from food animals to humans through the ingestion of
contaminated food. In the United States, 1.4 million nontyphoidal
Salmonella infections are thought to occur in humans annually,
resulting in approximately 15,000 hospitalizations and 400 deaths
[1]. An efficient surveillance system for salmonellosis is therefore
crucial. Various non exclusive strategies have been developed,
including sentinel surveillance, periodic population-based surveys,
and laboratory-based surveillance. Laboratory-based approaches
are a key component of monitoring strategies in developed
countries. They require a network of clinical laboratories covering
the population and referring isolates or information to a central
public health reference laboratory. The speed with which public
health laboratories obtain information after the onset of symptoms
and the regular sharing of information between public health
laboratories and epidemiologists are critical for the successful use
of information to detect outbreaks early and to identify their
source. The basic information currently provided by laboratories is
the serotype of the isolates. Hence, each year, more than 200,000
human isolates of Salmonella are serotyped in the United States and
Europe [2,3]. Serotyping, the reference method for Salmonella
typing since the 1930s, is based on the determination of two
surface antigens– O-polysaccharide and flagellin proteins – by
agglutination with a large set of polyclonal rabbit antisera. This
technique can recognize more than 2,500 serotypes [4], but its
discriminatory capacity is limited, because two serotypes, Typhi-
murium and Enteritidis, are highly prevalent worldwide and
account for most outbreaks. The sensitivity of serotyping for the
detection of outbreaks involving these common serotypes, even
with the use of cluster-detection algorithms, is therefore unsatis-
factory [5].
Differentiation between isolates within the most common
serotypes requires the use of subtyping methods, which were
initially based on determination of the sensitivity of certain
Salmonella serotypes to several bacteriophage suspensions (phage
typing) [6]. DNA-based subtyping methods were subsequently
developed, including, in particular, pulsed-field gel electrophoresis
(PFGE) [7], which is based on analysis of the restriction pattern of
high-molecular weight DNA digested with a rare-cutting restric-
tion enzyme. Real-time subtyping methods have increased the
power of laboratory-based surveillance to detect outbreaks,
distinguishing them from the background of sporadic cases by
identifying the phage type or molecular ‘‘fingerprint’’ of an
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this purpose. This real-time subtype surveillance has been
implemented in the US through PulseNet, an internet-based
network of public health and food regulatory agency laboratories
that perform real-time standardized PFGE and submit normalized
PFGE patterns or raw TIFF gel images electronically to a national
database. Regular searches of this database are made, with a view
to identifying clusters of identical patterns. However, PFGE has
several limitations: it is a technically demanding, non automated
method. This may explain why, in a study of outbreaks of food-
infection occurring in the US in 2002, the median interval from
the onset of symptoms to PFGE results was 18, with a period of 10
days elapsing between the submission of isolates to public health
laboratories and PFGE results [8]. Furthermore, the interpretation
and comparison of banding profiles is not straightforward, even
with standard protocols and analysis software. The discovery of
short DNA sequence repeats in the genomes of prokaryotic
organisms has recently led to the development of new subtyping
methods. Multilocus variable number of tandem repeats (VNTR)
analysis (MLVA) is based on the number of contiguous DNA
repeats present at several loci. Following a repeat-spanning PCR
for each locus, the number of repeats can be determined by
sequencing or inferred from electrophoresis (molecular weight
being correlated with the number of repeats). An MLVA scheme
for serotype Typhimurium based on the analysis of five loci (with
repeat units of 6 to 33 bp) has been established and evaluated [9].
Unlike PFGE, MLVA is rapid, technically simple and suitable for
the processing of large numbers of isolates. It can also distinguish
between clonal isolates indistinguishable by PFGE, such as those
belonging to the multidrug-resistant DT104 strain. However, this
method has several drawbacks. MLVA schemes have been
validated (i.e., shown to meet performance and convenience
criteria, including the epidemiological concordance required for
typing methods for use in bacterial epidemiology [10]) for only two
Salmonella serotypes, Typhimurium and Enteritidis [11–13]. It
requires a capillary electrophoresis system and it is difficult to size
fragments accurately, as observed in multicenter studies. Finally,
these repetitive DNA sequences may evolve too rapidly, leading to
changes in repeat numbers during the course of an outbreak
[12,13]. MLVA is therefore often used in addition to existing
subtyping methods, such as PFGE or phage typing.
Jansen et al. identified a new family of repeated DNA sequences,
named CRISPR (clustered regularly interspaced short palindromic
repeats) in many prokaryotes [14]. This family is characterized by
24–47 bp DNA direct repeats (DRs), separated by variable 21–
72 bp sequences called ‘‘spacers’’ [15,16]. A ‘‘leader sequence’’
and cas (CRISPR-associated sequence) genes are often identified
adjacent to the CRISPR locus. Since the middle of the 1990s, the
CRISPR locus of Mycobacterium tuberculosis has been extensively
studied and the high degree of polymorphism of its spacer content
has led to the development of a subtyping method known as
spoligotyping [17]. Subtyping methods based on analyses of the
spacers of CRISPR loci have since been developed for bacteria of
medical interest, such as Yersinia pestis [18], Corynebacterium
diphtheriae [19] and Campylobacter [20]. CRISPR seem to confer
resistance to foreign DNA, such as plasmids and phages, and the
newly integrated spacers are derived from the invading DNA
[21,22]. Interestingly, these spacers are integrated into the
CRISPR locus in a polarized manner [18,21]. The spacer content
of a strain therefore reflects previous DNA introductions and can
provide evolutionary information.
Several studies have reported the presence of two CRISPR loci
in Salmonella [14,23,24]. We previously showed, in a preliminary
study of 400 Salmonella enterica and Salmonella bongori reference
strains and isolates from 56 serotypes, that CRISPR polymor-
phisms (i.e., spacer content) were strongly correlated with serotype
and subtype [25]. Two studies recently suggested that CRISPR
loci might provide information useful for typing [26,27]. However,
these studies considered only a limited number of serotypes from a
single geographic area.
We aimed to demonstrate that CRISPR polymorphism analysis
is an efficient and powerful alternative to both serotyping and
PFGE methods. We first analyzed the spacer content of the two
Salmonella CRISPR loci in a large global collection of reference
strains and well documented isolates belonging to 130 serotypes of
all species and subspecies, focusing particularly on the serotypes
most frequently involved in human infections. Analysis of the
distribution of the .3,800 unique spacers identified showed that
spacer content was strongly correlated with both serotype and
multilocus sequence typing (MLST) type. Furthermore, the
microevolution of spacer content facilitated the robust discrimi-
nation of subtypes within most serotypes, including the most
prevalent serotypes, Typhimurium and Enteritidis.
We also present here three applications of CRISPR polymor-
phisms for Salmonella surveillance. In particular, we describe a
novel high-throughput subtyping assay for serotype Typhimurium
(and its emerging monophasic 1,4,[5],12:i:- variant). This bead-
based liquid hybridization assay is both rapid and easy to carry
out, and is therefore highly suitable for use in public health
laboratories.
Results
In silico Analysis of the Organization and Structure of
CRISPR Loci in Salmonella
Two CRISPR loci, CRISPR1 and CRISPR2, were separated
by less than 20 kb in all 39 complete genomes of S. enterica and S.
bongori analyzed (Figure 1, Table 1). The CRISPR1 locus was
located downstream from the iap gene, whereas CRISPR2 was
located upstream from the ygcF gene. The ordered CRISPR-
associated (cas) genes belonging to the Ecoli subtype defined by
Haft et al. [28] were located between the CRISPR loci: cas2, cas1,
cse3, cas5e, cse4, cse2, and cas3. Following the cas genes were sopD
(encoding a secreted effector protein), cysH (encoding a phosphoa-
denosine phosphosulfate reductase), cysI, cysJ (both encoding sulfite
reductase subunits), ptpS (encoding pyruvyl tetrahydrobiopterin
synthase) and an ORF encoding a putative metal-dependent
hydrolase. Structure A was the most frequent, and was observed in
26 (67%) genomes of S. enterica subsp. enterica (including represen-
tative serotype Typhimurium strain LT2), S. enterica subsp.
diarizonae and S. bongori. Structure B, which was found only in
serotype Choleraesuis SC-B67, differed from structure A by an
insertion sequence, ISSen1, immediately upstream from CRISPR2.
Structure F, which was found in nine genomes of S. enterica subsp.
enterica (including representative serotype Typhi strain Ty2)
differed from structures A and B in having a different orientation
of the cas3 gene and in terms of the degree of similarity of Cas
proteins (40 to 85%, depending on the Cas proteins considered;
data not shown) [23]. In structures C, D and E (found in S. enterica
serotype Paratyphi B strain SPB7, S. enterica subsp. arizonae serotype
62:z4,z23:- strain CDC346-86, and S. enterica serotype Javiana
strain GA_MM04042433, respectively), there was a deletion
beginning at the end of the last DR of CRISPR1 and
encompassing all cas genes with the exception of a 59 remnant of
cas3, which was in the same orientation as that in structure A.
The DRs of both CRISPR loci were conserved. They were
29 bp long and had the consensus sequence 59-
CGGTTTATCCCCGCTGGCGCGGGGAACAC-39. However,
CRISPR Polymorphisms in Salmonella
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(SNPs) with respect to the consensus sequence were observed
(Table S1).
There were 705 unique spacers between the DRs in the two loci
from the 39 available genomes (Table S2). Depending on the
genome, the number of CRISPR1 spacers varied from 1 to 55
(mean 18.66standard deviation 13.6) and of the number of
CRISPR2 spacers varied from 0 (subsp. arizonae) to 32 (15.069.8).
Spacers were typically 32 bp long (681/705). One was 29 bp long,
two were 31 bp long, sixteen were 33 bp long, one was 38 bp long
(spacer STM18var2, which contained a VNTR) one was 50 bp
long, one was 72 bp long and two were 74 bp long (spacers
STM7A/7B and STM7A/7Bvar2 of serotype Typhimurium) (see
below). Some spacers were common to different serotypes.
While our study was underway, two CRISPR databases
(CRISPRdb and CRISPI) went online [15,29]. These generalist
databases containing .1500 prokaryote genomes incorporate
various bioinformatics tools, including one for identifying CRISPR
sequences in a selected genome. The application of this tool to
Salmonella genomes resulted in incorrect results for four to six of the
17 genomes present in both databases. CRISPRfinder did not
detect the short CRISPR2 locus of serotype Typhi strains Ty2 and
CT18, which have a unique spacer (EntB0var1) between two DRs
(DR27 and DR), one of which is degenerate (identity of 20/29 bp).
CRISPRfinder detected three CRISPR in serotype Typhimurium
strain LT2 and serotype Heidelberg strain SL476. The CRISPR1
locus was actually artificially split into two CRISPR, due to the
presence of an unusual fused spacer-DR unit (STM7A/7B, see
below). The CRISPI tool detected no CRISPR in four genomes
and only one CRISPR in two others. The CRISPR loci identified
in all six genomes were short (1 to 6 spacer-DR units) in our study,
confirming that the CRISPI tool is not suitable for detecting short
CRISPR loci. Thus, although bioinformatics tools are undoubt-
edly useful for screening for CRISPR within genomes, careful
manual inspection is required to complete the analysis for a given
species.
Spacer Content is Strongly Associated with Serotype
and MLST
PCR amplification of CRISPR1 with primers A1 and A2
generated a product of between 400 bp and 3 kb in size, in 639
of 744 strains and isolates. By contrast PCR amplification of
CRISPR2 with primers B1, B2 and B3 generated a product of
between 500 bp and 3 kb in size in all but subsp. arizonae strains
and isolates (Figure 1, Tables 2 and S2). Various deletions
downstream from CRISPR1 or upstream from CRISPR2 were
responsible for amplification failure (see below and Table 3). In
one reference strain of serotype Mbandaka, PCR was unsuccessful
because the CRISPR1 locus was very large (.6 kb) and contained
124 spacer-DR units.
More than 3,800 different spacers (mean length of 32
nucleotides) were identified in the 39 available genomes and 744
strains and isolates tested (Tables S2, S3, S4). The number of
spacers present in a given strain ranged from 1 to 124 for
CRISPR1, and from 0 (subsp. arizonae) to 50 for CRISPR2 (Table
S3). Two rare groups of strains displayed low levels of correlation
between spacer content and serotype or MLST type. First, all the
reptile-associated subsp. arizonae strains had the same single
Figure 1. CRISPR/Cas system structures from 39 available genome sequences for S. enterica and S. bongori. Two CRISPR loci (CRISPR1
and CRISPR2) are present in all genomes. The CRISPR-associated (cas) genes cas2, cas1, cse3, cas5e, cse4, cse2, and cas3 genes of the ‘‘Ecoli’’ subtype
[28] are located between the CRISPR loci. The most frequent structure, A, is represented by S. enterica serotype Typhimurium strain LT2. Structures B
to E are represented by S. enterica serotypes Choleraesuis strain SC-B67, Javiana strain GA_MM04042433, Paratyphi B strain SPB7, and S. enterica
subsp. arizonae serotype 62:z4,z23:- strain CDC346-86, respectively. Structure F is represented by S. enterica serotype Typhi strain Ty2. Black diamonds
represent direct repeats, with colored diamonds indicating spacers. The CRISPR1 locus of serotype Typhi strain Ty2 is enlarged. The primers used to
amplify and sequence the CRISPR loci for the spacer inventory are indicated by horizontal arrows.
doi:10.1371/journal.pone.0036995.g001
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Strain Source (accession no.)
CRISPR
structure CRISPR1 coordinates CRISPR2 coordinates
S. enterica subsp. enterica serotype:
Agona strain SL483 GenBank (CP001138) A 2988105-2989231 (18) 3005517-3006033 (8)
Choleraesuis strain SC-B67 GenBank (AE017220) B 3031533-3031805 (4) 3049243-3049698 (7)
Dublin strain CT_02021853 GenBank (CP001144) A 3121101-3121251 (2) 3137409-3137742 (4)
Enteritidis strain P125109 GenBank (AM933172) A 2961370-2961886 (8) 2978038-2978677 (10)
Gallinarum strain 287/91 GenBank (AM933173) A 2952175-2952325 (2) 2968478-2969117 (10)
Hadar strain RI_05P0661 GenBank (ABFG00000000) F NA (28) NA (29)
Hadar strain ‘‘Sanger’’1 Sanger Institute2 F NA (28) NA (30)
Heidelberg strain SL476 GenBank (CP001120) A 3051217-3052879 (28) 3069137-3070263 (18)
Heidelberg strain SL4861 GenBank (ABEL00000000) A NA (26) NA (18)
Infantis ‘‘Sanger’’ 1 Sanger Institute2 A NA (31) NA (14)
Javiana strain GA_MM040424331 GenBank (ABEH00000000) C NA (6) NA (12)
Kentucky strain CDC1911 GenBank (ABEI00000000) A NA (19) NA (18)
Kentucky strain CVM291881 GenBank (ABAK00000000) A NA (18) NA (17)
Newport strain SL254 GenBank (CP001113) F 3054859-3056473 (26) 3073142-3074328 (19)
Newport strain SL3171 GenBank (ABEW00000000) A NA (12) NA (18)
Paratyphi A strain ATCC 9150 GenBank (CP000026) F 2889569-2889902 (5) 2906453-2906664 (3)
Paratyphi A strain AKU_12601 GenBank (FM200053) F 2885105-2885560 (7) 2902111-2902322 (3)
Paratyphi B strain SPB7 GenBank (CP000886) D 3041329-3041479 (2) 3050804-3051137 (5)
Paratyphi C strain RKS4594 GenBank (CP000857) A 3010604-3011242 (10) 3028681-3029258 (9)
Saintpaul strain SARA231 GenBank (ABAM00000000) A NA (13) NA (26)
Saintpaul strain SARA291 GenBank (ABAN00000000) A NA (19) NA (7)
Schwarzengrund strain CVM19633 GenBank (CP001127) F 2981949-2982709 (12) 2999469-3000534 (17)
Schwarzengrund strain SL4801 GenBank (ABEJ00000000) F NA (12) NA (17)
Tennessee strain CDC07-01911 GenBank (ACBF00000000) A NA (41) NA (21)
Typhi strain CT18 GenBank (AL627276) F 2926182-2926567 (5) 2943123-2943212 (1)
Typhi strain Ty2 GenBank (AE014613) F 2912041-2912461 (6) 2929017-2929106 (1)
Typhimurium strain LT2 GenBank (AE006468) A 3076611-3078147 (23) 3094279-3096260 (32)
Typhimurium strain SL1344 GenBank (FQ312003) A 3099172-3100159 (15) 3116291-3117723 (22)
Typhimurium strain D23580 GenBank (FN424405) A 3069598-3071012 (22) 3087144-3088271 (18)
Typhimurium strain 14028S GenBank (CP001363) A 3096848-3098323 (23) 3114455-3116070 (25)
Typhimurium strain T000240 GenBank (AP011957) A 3100041-3101393 (21) 3117525-3119506 (32)
Typhimurium strain DT21 Sanger Institute2 A NA (21) NA (26)
Typhimurium strain NCTC 133481 Sanger Institute2 A NA (10) NA (26)
Virchow strain SL4911 GenBank (ABFH00000000) A NA (55) NA (16)
Weltevreden strain HI_N05-5371 GenBank (ABFF00000000) A NA (40) NA (26)
4,5,12:i:- strain CVM237011 GenBank (ABAO00000000) A NA (23) NA (26)
S. enterica subsp. arizonae serotype:
62:z4,z23:- strain CDC346-86 GenBank (CP000880) E 25560-25471 (1) 17801-17773 (0)
S. enterica subsp. diarizonae serotype:
61:l,v:1,5,7 strain CDC01-00051 Washington State University3 A NA (30) NA (1)
S. bongori serotype:
66:z41:- strain 12419 Sanger Institute2 A 2791744 -2792992 (20) 2808974 -2810039 (20)
1Genomes not finished or annotated.
2These data were provided by Dougan’s group at the Wellcome Trust Sanger Institute and could be obtained from http://www.sanger.ac.uk/resources/downloads/
bacteria/salmonella.html.
3Available from http://genome.wustl.edu/genomes/.
4NA, not applicable; the number of spacers per locus is indicated in brackets.
doi:10.1371/journal.pone.0036995.t001
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Second, some reptile-associated subsp. enterica serotypes, such as
Urbana, Johannesburg, Reading, Pomona, Gueuletapee, Rubis-
law, Goettingen and Sandiego had a limited set of spacers shared
between these serotypes that belonged to a highly recombinogenic
group known as clade B [30] or lineage 3 [31]. Both groups of
strains displayed deletions (DA10 for subsp. arizonae serotypes and
DF4 and DF5 for clade B subsp. enterica serotypes) of the cas genes
(see below). However, with the exception of these two groups,
spacer content was strongly correlated with serotype and/or
MLST type for 730 of 744 (98.1%) strains. Moreover, for
polyphyletic serotypes comprising unrelated MLST groups, spacer
content was strongly correlated with the population structure
defined by MLST (Table S2). For example, the CRISPR data for
three recently described genetic lineages of serotype Newport [32],
gave correct serotype recognition and genetic lineage assignment
(Tables 4 and S5).
Most of the spacers were unique to particular serotypes. The
degree of spacer sharing varied among groups of serotypes
identified as closely related on the basis of MLST. For example, in
serotypes such as Typhimurium (4:i:1,2) Heidelberg (4:r:1,2) and
Kisangani (4:a:1,2), all the spacers on the iap gene side tended to
be the same whereas the spacers present on the leader side tended
to be more serotype-specific. For isolates of the ST11 group of
serotype Enteritidis (9,12:g,m:-) and the closely related Gallinarum
(9,12:-:-) and Dublin (9,12:g,p:-) serotypes, only a subset of
common spacers was identified (Tables 5 and S6). This was also
the case for the complex group of ‘‘bioserotypes’’ Paratyphi C,
Choleraesuis (sensu stricto and variant Kunzendorf), and Typhisuis,
which have the antigenic formula 6,7:c:1,5 in common, indicating
descent from a common ancestor, consistent with MLST data
(Figure 2). The presence of ISSen1 at the same position upstream
from CRISPR2 in these bioserotypes is also consistent with the
hypothesis of a common ancestor. By contrast, the polyphyletic
serotype Decatur (formerly known as serotype Choleraesuis
variant Decatur which also has an antigenic formula of 6,7:c:1,5)
did not have an ISSen1 element upstream from CRISPR2 and
included various spacers not found in Paratyphi C, Choleraesuis
and Typhisuis (Table S2).
Deletions Downstream from CRISPR1 and Upstream from
CRISPR2 in some Salmonella Populations
For representative strains or isolates for which no PCR was
obtained from CRISPR1 or CRISPR2, we carried out a long-
range PCR encompassing both CRISPR loci, with primers A1 and
B3. Amplicons were obtained from all isolates and were between
10 kb and 20 kb in size. DNA sequencing of the ends of the PCR
products showed that amplification failure resulted principally
from large deletions affecting the cas genes, ending at the cas3 gene
and preventing the annealing of the A2 primer (Table 3). For
subsp. arizonae and serotypes Paratyphi B and Javiana, these
deletions were consistent with data for the three corresponding
available genome sequences and from Fricke et al. [24]. Such
deletions were also observed in other serotypes or populations
within a single serotype, but they were of different types. We
therefore designed and validated new CRISPR1 reverse primers
binding to the residual region of the cas3 gene from structure A (A3
and A4) or F (A5 to A7) (Table 2). Due to a deletion upstream
from CRISPR2, the B1 primer did not bind to DNA from subsp.
arizonae. However, the available genome sequence and sequencing
of the long PCR fragment generated with the A1 and B3 primers
Table 2. Primers used for the spacer content inventory.
Primer Sequence 59-39
1
Coordinates in Salmonella
genomes
2 Function
3
A1 GTRGTRCGGATAATGCTGCC AE006468 (3076537-3076556)
AE014613 (2911967-2911986)
Forward primer for amplification of CRISPR1 or for combined amplification
of both CRISPR1 and CRISPR2 loci
A2 CGTATTCCGGTAGATBTDGATGG AE006468 (3078306-3078284)
AE014613 (2912608-2912586)
Reverse primer for amplification of CRISPR1 in 640 (86%) of the isolates
A3 CTATTTTGGRCTRCCGACRATG AE006468 (3085738-3085717) Reverse primer for amplification of CRISPR1 in 60 (8.1%) isolates of type A
structure
A4 GCAATCGGAGCGATTGATGGC AE014613 (2920120-2920100) Reverse primer for amplification of CRISPR1 in 29 (3.9%) isolates of type F
structure
A5 TCAACACTCTCTTCACCCAG AE014613 (2921235-2921216) Reverse primer for amplification of CRISPR1 in 7 (0.9%) isolates of type F
structure
A6 TAACCAGCCCTCTTCTGCCTG AE014613 (2920910-2920892) Reverse primer for amplification of CRISPR1 in 2 (0.3%) isolates of type F
structure
A7 CGCATCATCAACCGTGTTGCG AE014613 (2920524-2920504) Reverse primer for amplification of CRISPR1 in 6 (0.8%) isolates of type F
structure
B1 GAGCAATACYYTRATCGTTAACGCC AE006468 (3094155-3094179)
AE014613 (2928893-2928917)
Forward primer for amplification of CRISPR2
B2 GTTGCDATAKGTYGRTRGRATGTRG AE006468 (3096328-3096303)
AE014613 (2929174-2929150)
Reverse primer for amplification of CRISPR2 for the isolates belonging to
subspecies other than arizonae and diarizonae
B3 CTGGCGGCTGTCTATGCAAAC AE006468 (3096602-3096582)
AE014613 (2929448-2929428)
Reverse primer for single amplification of CRISPR2 for the isolates
belonging to all subspecies or reverse primer for combined amplification of
both CRISPR1 and CRISPR2 loci
1Degenerate positions: R=G or A; Y=T or C; M=A or C; K=G or T; D=G or A or T; B=G or T or C.
2AE006468, serotype Typhimurium LT2 strain; AE014613, serotype Typhi Ty2 strain.
3The primer pairs used for CRISPR1 amplification for each of the 744 strains are indicated in Table S2.
doi:10.1371/journal.pone.0036995.t002
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(DR68) and no CRISPR2 spacer in this subspecies.
Microvariations of the Spacer Content Discriminate
below the Serotype Level
We observed stable microvariation (duplication, triplication, loss
or gain of spacers, presence of SNP variant spacers or VNTR
variant spacers) within the strains of monophyletic serotypes. This
was the case for the most prevalent serotype worldwide,
Typhimurium and its monophasic 1,4,[5],12:i:- variant, for which
we analyzed eight genomes and 150 well characterized isolates
collected between 1947 and 2010 (Table S7).
In silico analysis of genome sequences identified 28 unique
spacers within CRISPR1. This number increased to 40 after
analysis of the additional 150 isolates (between 6 and 31 spacers
per isolate). The order of spacers was strictly conserved. Most were
32 bp (31/40) or 33 bp (2/40) long. Four of the 40 spacers had
SNP variants, one (STM18) had four VNTR variants (26 to
50 bp), and the 74 bp STM7A/7B and STM7A/7Bvar2 spacers
contained a 28 bp spacer fused to 14 bp from the end of a DR
followed by a classical 32 bp spacer (Figure S1). This fusion
spacer-DR unit may have been generated accidentally during the
process of spacer acquisition.
In silico analysis identified 36 unique spacers within CRISPR2.
This number increased to 39 upon sequencing of the additional
150 isolates (between 4 and 40 spacers per isolate). All spacers
were 32 bp (38/39) or 33 bp (1/39) long. The 39 spacers included
only two variant spacers (SNP variants, all the other spacers being
unrelated). As for CRISPR1, the variability of CRISPR2 was due
to duplication of a single spacer (STMB13)-DR unit and/or to
deletion of single or contiguous spacer-DR units.
The order of the spacers was strictly conserved in all but four
alleles of CRISPR2 (8 isolates). The variability of CRISPR1 and
CRISPR2 spacer content resulted from the duplication of single
spacer (STM5, STM8, STM22, STM28, and STMB13)-DR units
and/or the deletion of single or contiguous spacer-DR units. This
microvariation resulted in 57 CRISPR1 and 62 CRISPR2 alleles
or into 83 CRISPR1-CRISPR2 combined alleles, thus providing a
higher resolution than other subtyping methods, such as PFGE.
Particular populations, such as multidrug-resistant (MDR) DT104
Table 3. Serotypes with deletions of the Cas machinery.
Name Deleted cas2-cas3 region
1
cas3 remnant size in
bp
2 Serotypes with such deletion (no. of isolates)
Type A CRISPR structure
DA1 3078148-3084080 2622 Stourbridge (7)
DA2 3078148-3084337 2365 Kundunchi (1)
DA3 3078148-3084606 2096 Choleraesuis (2)
DA4 3078148-3084649 2053 Napoli (1)
DA5 3078148-3084656 2046 Mbandaka (2)
DA6 3078148-3084763 1939 Javiana (4)
DA7 3078148-3084995 1707 Abony (1), Paratyphi B (25)
DA8 3078148-3085040 1662 Enteritidis (1)
DA9 3078148-3085289 1413 subsp. indica 6,7:z41:1,7 (1)
DA10 3078148-3085385 1317 All subsp. arizonae (5)
DA11 3078148-3085559 1143 Enteritidis (1)
DA12 3078148-3085681 1021 Worthington (12)
Type F CRISPR structure
DF1 2912462-2919593 1406 (1899) subsp. houtenae 48:g,z51:- (1)
DF2 2912462-2919670 1329 (1822) Portedeslilas (1)
DF3 2912462-2919881 1118 (1611) Newport (5)
DF4 2912462-2919890 1109 (1602) Johannesburg (1), Urbana (2)
DF5 2912462-2919901 1098 (1591) 9,12:l,v:- (1), Arechavaleta (1), Brandenburg (3), Chester (1), Glostrup (1), Goettingen
(1), Gueuletapee (1), Maracaibo (1), Miami (4), Panama (3), Pomona (2), Reading (1),
Rubislaw (1), Sandiego (1)
DF6 2912462-2920094 905 (1398) Albany (1), Duesseldorf (1)
DF7 2912462-2920154 845 (1338) Choleraesuis (1)
DF8 2912462-2920810 189 (682) subsp. houtenae 1,40:z4,z24:- and 44:a:- (2)
DF9 2912462-2920937 62 (555) Bardo (1), Newport (1)
DF11 2912462-2921077 0 (415) Carrau (1), Madelia (1)
DF12 2912462-2921188 0 (303) Newport (3)
1The coordinates of the deleted regions of isolates with type A CRISPR structure and those of isolates with type F CRISPR structure are based on S. enterica serotype
Typhimurium strain LT2 (GenBank AE006468) and serotype Typhi strain Ty2 (GenBank AE014613) genomes, respectively. The reverse primers used for these isolates are
indicated in Table 2.
2The cas3 gene of serotype Typhimurium LT2 strain is 2663 bp in size, whereas that of serotype Typhi strain Ty2 is 2207 bp in size, due to a frameshift leading to a
premature stop codon. The sizes of the cas3 gene remnant are shown in brackets, not taking into account the serotype Typhi-specific frameshift.
doi:10.1371/journal.pone.0036995.t003
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resistant isolates [35], each had typical CRISPR alleles.
In vitro stability experiments showed no difference in spacer
content for either of the CRISPR loci between the five original
serotype Enteritidis isolates and their derived cultures after one
month or two months with daily passages. Furthermore, the
genome sequences of widely used laboratory strains of serotype
Typhimurium, LT2 (isolated in 1947) and SL1344 (isolated in the
1970s), showed these strains to have the same spacer content (15 to
32 per locus) as strains LT2 and SL1344 available in our
laboratory. The stability of this marker was also assessed by
performing the microbead-based CRISPOL assay (see below) one
year later on fresh cultures (grown from single colonies) of the 150
serotype Typhimurium and monophasic 1,4,[5],12:i:- isolates
(mean of 4169 spacers per isolate). One isolate had a discordant
CT with respect to the initial spacer content determined by
sequencing. We resequenced both CRISPR loci in this subcul-
tured isolate and found that a single CRISPR1 spacer-DR unit
had been lost. During the systematic CRISPOL testing of all
serotype Typhimurium and monophasic isolates obtained between
January 1 2010 and July 7 2010, 43 duplicate and four triplicate
isolates obtained from the same patients on different days were
analyzed (see below). All but one had concordant CTs. The final
isolate had lost a CRISPR1 spacer-DR unit that was present in the
other two isolates from the same patient. Thus, spacer content is,
at least in serotypes Enteritidis and Typhimurium, stable enough
for use in surveillance and outbreak investigation. However,
although rare and often minor (single spacer variant of the original
CT in both cases detected), CRISPR variation may occur and,
whatever its origin, occurring before or during carriage in the
patient or subculture in the laboratory, should be taken into
account when defining outbreak-related CTs.
We assessed the discriminatory power of the method, an
important parameter for surveillance purposes, by comparing
CRISPR spacer diversity with classical first-line (PFGE, phage
typing) and second-line (MLVA) subtyping methods for a subset of
Table 4. Comparison of CRISPR1 spacer content with the population structure of S. enterica serotype Newport, as assessed by
MLST.
Lineage Strain MLST
1 CAS type(deletion)
2 CRISPR1 spacer content
3
Newport-I 00-4093 ST156 Ty2 (DF3) Ind1var1-H1-H2-H3-H4-H5-H7-H8-H9-N32-H14-N33-N51-N52-N53-Bovis3-H15-N54-
N55-DueB1-N56-N60-N61-N57-N58-N59
01-2174 ST156 Ty2 (DF3) Ind1var1-H1-H2-H3-H4-N55-DueB1-N56-N60-N61-N57-N58-N59
00-973 ST166 Ty2 (DF3) Ind1var1-H1-H2-H3-H4-H5-H7-H8-H9-N32-H14-N33-N51-N52-N53-Bovis3-H15-N54-
N55-DueB1-N56-N62-N60-N61-N57-N58-N59
04-2487 ST166 Ty2 (DF3) Ind1var1-H1-H2-H3-H4-H5-H7-H8-H9-N32-H14-N33-N51-N52-N53-Bovis3-H15-N54-
N55-DueB1-N56-N62-N60-N61-N57-N59
39/64 ST166 Ty2 (DF3) Ind1var1-H1-H2-H3-H4-H5-H7-H8-H9-N32-H14-N33-N51-N52-N53-Bovis3-H15-N54-
N55-DueB1-N56-N60-N61-N57-N58-N59
Newport-II 10/66 ST45 Ty2 H7-N1-H8-N2-N3-N4-N5-N31-N6-N7-N8-N9-N10-N22-N12-N14-N15-N16-N17-N18-N21
00-4165 ST45 Ty2 H7-N1-H8-N2-N3-N4-N5-N6-N7-N8-N9-N10-N22-N23-N24-N11-N12-N13-N14-N15-
N16-N17-N18-N19-N20-N21
02-7891 ST45 Ty2 H7-N1-H8-N2-N3-N4-N5-N6-N7-N8-N9-N10-N22-N23-N24-N11-N12-N13-N14-N15-
N16-N17-N18-N19-N20-N21
04-9597 ST45 Ty2 H7-N1-H8-N2-N3-N4-N5-N6-N7-N8-N9-N10-N22-N23-N24-N11-N12-N13-N14-N15-
N16-N17-N18-N19-N20-N21
SL254 ST45 Ty2 H7-N1-H8-N2-N3-N4-N5-N6-N7-N8-N9-N10-N22-N23-N24-N11-N12-N13-N14-N15-
N16-N17-N18-N19-N20-N21
01-2010 ND Ty2 H7-N1-H8-N2-N3-N4-N5-N6-N7-N8-N9-N10-N22-N23-N24-N11-N12-N13-N14-N15-
N16-N17-N18-N19-N20-N21
03-3224 ND Ty2 H7-N1-H8-N2-N3-N4-N5-N6-N7-N8-N9-N10-N22-N23-N24-N11-N12-N13-N14-N15-
N16-N17-N18-N19-N20-N21
10/56 ST46 Ty2 H7-N1-H8-NB25var1-N26-N27-N2-N28-N3-N4-N5-N31-N6-N7-N8-N24-N11-N12-N13-
N29-N30-N16-N17-N18-N19-N21
50K ST31 Ty2 (DF12) H7-N1-H8-NB25var1-N26-N27-N2-N28-N3-N4-N5-N31-N6-N7-N8-N9-N23-N24-N11-
N12-N13-N29-N30-N14-N15-N16-N17-N18-N19-N20
04-1198 ST31 Ty2 (DF12) H7-N1-N17-N18-N19-N20
50/3 ST31 Ty2 (DF12) H7-N1-H8-NB25var1-N26-N27-N2-N28-N3-N4-N5-N31-N6-N7-N8-N9-N23-N24-N29-
N30-N14-N15-N16-N17-N18-N19-N20
2/58 ST211 Ty2 (DF9) H7-N1-H8-NB25var1-N26-N27-N2-N28-N3-N19-N20-N21
Newport-III 05-0815 ST118 LT2 STM1var1-N45-N34-N35-N36-N37-N38-N39-N40-N46-N47-N48-N49-N42-N43-N44
4/51 ST118 LT2 STM1var1-N45-N35-N36-N37-N38-N39-N40-N46-N47-N48-N49-N50-N42-N43
03-8748 ST118 LT2 STM1var1-N45-N34-N35-N36-N46-N47-N48-N42-N43-N44
SL317 ST5 LT2 STM1var1-N34-N35-N36-N37-N38-N39-N40-N41-N42-N43-N44
1ND, Not done.
2The deletions are named according to Table 3.
3Due to space constraints, the spacer names Newp and Had are abbreviated to N and H, respectively.
doi:10.1371/journal.pone.0036995.t004
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found 17 different alleles for CRISPR1 (Simpson’s discrimination
index (DI)=0.84), 23 for CRISPR2 (DI=0.84), and 26 if a
combination of the two loci was considered (DI=0.88). These
isolates gave 26 XbaI-PFGE profiles (DI=0.87) and 14 phage
types (DI=0.74). For prevalent MDR DT104 isolates, the
discriminatory power was higher for combined CRISPR analysis
(5 profiles, DI=0.64) than for PFGE (also 5 profiles, but
DI=0.38). The best discrimination was that achieved with the
five-locus loci MLVA method, for which all the DT104 isolates
had different profiles (DI=1). However, it was not possible to
amplify some MLVA loci from some isolates (null alleles were seen
Table 5. CRISPR1 spacer content in various O:9 and O:2 serotypes.
Serotype
Antigenic
formula Biotype MLST No. of isolates CRISPR1 spacer content
Enteritidis 9,12:g,m:- ST11 group1
1 Ent1
2 Ent1-Dub1-Ent3-Ent8
2 Ent1-Ent2-Ent3-Ent4-Ent4-Ent5-Ent6-Ent7-Ent8
1 Ent1-Ent2-Ent3-Ent4-Ent5
76 Ent1-Ent2-Ent3-Ent4-Ent5-Ent6-Ent7-Ent8
7 Ent1-Ent2-Ent3-Ent4-Ent5-Ent6-Ent7-Ent9-Ent8
10 Ent1-Ent2-Ent3-Ent4-Ent5-Ent7-Ent8
7 Ent1-Ent2-Ent3-Ent4-Ent5-Ent7-Ent9-Ent8
1 Ent1-Ent2-Ent3-Ent4-Ent5var1-Ent6-Ent7-Ent9-Ent8
92 Ent1-Ent2-Ent3-Ent5-Ent6-Ent7-Ent9-Ent8
1 Ent1-Ent2-Ent5-Ent6
1 Ent1-Ent2-Ent5-Ent6-Ent7-Ent8
1 Ent1-Ent2var1-Ent3-Ent4-Ent5-Ent6-Ent7-Ent8
51 Ent1-Ent2var1-Ent3-Ent4-Ent5-Ent6-Ent7-Ent9-Ent8
2 Ent1-Ent3-Ent5-Ent6-Ent7-Ent9-Ent8
Other STs
ST180 1 Ent1-Ent5-Ent6-Ent10-Ent11-Ent7-Ent9-Ent12
ST180 1 Ent1-Ent5-Ent6-Ent10-Ent11-Ent7var1-Ent12
ST180 1 Ent1-Ent5-Ent6-Ent10-Ent7-Ent12
ST6 1 Ent16-Ent17-Ent18-Ent19-Ent20?//?Ent353
ST77 1 STM1-Ent13-EmeB14-Ent14-CholB19-Ent15
9,12:g,m,p:- ST74 1 Ent1-Ent5-Ent6-Ent10-Ent11-Ent7-Ent12
9,12:g,m,p:- ST74 1 Ent1-Ent5-Ent6-Ent11-Ent7-Ent12
9,12:g,m:1,7 ST746 1 Ent36-Mba9-Ent37-Ent38
Blegdam 9,12:g,m,q:- ST739 (ST11 SLV) 1 Ent1-Ent2-Ent3-Ent5-Ent6-Ent7-Ent9-Ent8
Rosenberg 9,12:g,z85:- ST11 2 Ent1-Ent2-Ent3-Ent4-Ent5-Ent6-Ent7-Ent8
ST11 1 Ent1-Ent2-Ent3-Ent4-Ent4-Ent5-Ent6-Ent7-Ent8
Dublin 9,12:g,p:- ST10 4 Ent1-Dub1
ST73 2 Ent1-Dub1
Gallinarum 9,12:-:-
Gallinarum ST78 7 Ent5-Ent6var1
Pullorum ST92 3 Ent3-Ent4
Pullorum ST747 (ST92 SLV) 1 Ent3-Ent4
Pullorum ST92 1 Ent1-Ent3-Ent4
Duisburg4 ST762 2 Ent1-Ent3-Ent4
Nitra 2,12:g,m:- ST11 2 Ent1-Ent2-Ent3-Ent4-Ent5-Ent6-Ent7-Ent8
ST11 1 Ent1-Ent2-Ent3-Ent5-Ent6-Ent7-Ent9-Ent8
Kiel 2,12:g,p:- ST10 3 Ent1-Dub1
1ST (sequence type) 11 group consists of ST11 and its single-locus variants (SLV).
2Includes the 5 ST136 ‘‘Danysz’’» strains used as rodenticides.
3Ent202//2Ent35, 15 unique spacers are located between Ent20 and Ent35 (see Table S2).
4Serotype Gallinarum biovar Duisburg is different from serotype Duisburg.
doi:10.1371/journal.pone.0036995.t005
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and STTR10 in 3 isolates) and variations in the number of repeats
of some loci were observed in outbreak-related isolates, indicating
lower levels of epidemiological concordance, possibly due to the
very rapid evolution of these markers or to outbreaks being caused
by more than two MLVA types (Table S7).
The spacer content of serotypes Typhimurium and Enteritidis
isolates from 10 documented outbreaks was studied by sequencing
(Tables S7 and S8) or with the microbead-based CRISPOL assay
(see below). In all cases, the outbreak isolates had the same
CRISPR type. Epidemiological concordance was thus complete.
Four strains (SARA8, 81-784, 02-7015 and 07-1777) with a
known spacer content covering all the spacers identified were
tested in every microbead-based CRISPOL experiment. Their
CRISPR types were identical in all cases.
In addition to 100% typeability, the other performance criteria
[10] for CRISPR analysis, such as stability, discriminatory power,
epidemiological concordance and reproducibility, indicated that
this was a very powerful method for use in the molecular
epidemiology of Salmonella.
Applications of CRISPR Polymorphisms
There are at least three applications of CRISPR polymorphisms
of potential interest in clinical microbiology or public health
laboratories.
Application 1: CRISPR sizing by PCR for the rapid
comparison of Salmonella spp isolates. The first application
is a double-locus PCR assay for the rapid comparison of Salmonella
isolates. We demonstrate above that variation in the number and
type of spacers can be used to track strains, given the
discrimination between the most prevalent Salmonella serotypes.
Remarkably, simple PCR amplification of CRISPR1 and
CRISPR2 loci, followed by agarose gel electrophoresis and sizing
of the PCR products, differentiated outbreak isolates from non
outbreak isolates and was therefore found to be a useful screening
approach. For example, for the eight isolates of serotype
Typhimurium isolated from the same city during a single week
in 2005 (cluster E in Table S7), it was possible to discriminate
between four isolates from the same food poisoning cluster and
four other isolates unrelated to this cluster (Figure 3). This size
variation results from variation in the number of spacer-DR units
(total 60 bp), which thus provides some discrimination even in the
absence of qualitative information (i.e., the spacer type). Another
advantage of this approach is that it does not require prior
serotype identification, as sequences from isolates of all serotypes
can be amplified by at least one of the two primer pairs used for
CRISPR amplification. A different amplicon size for one or both
loci demonstrates that the analyzed isolates are unrelated, but it
should be borne in mind that a similar amplicon size for both loci
does not necessarily imply that the two isolates belong to the same
strain. Two unrelated isolates could have the same number of
spacers but of different types, and low-level variation in the
number of spacers might not be detected on agarose electropho-
resis of large PCR products. However, this simple screening
approach is suitable for low-capacity public health or hospital
laboratories, including those in developing countries, which need
to be able to compare several Salmonella isolates rapidly in a single
experiment and that cannot afford complete serotyping or
subtyping by PFGE.
Application 2: High-throughput method for subtyping
serotype Typhimurium or its monophasic variant in real
time: the CRISPOL assay. We present below a second
Figure 2. Multilocus sequence typing and CRISPR spacer content of 34 S. enterica strains and isolates with the antigenic formula
6,7:c:1,5. Based on additional biochemical characters, we can identify five subserotypes: Choleraesuis sensu stricto, Choleraesuis variant Kunzendorf,
Paratyphi C (human-restricted), Typhisuis (pig-restricted) and Decatur. MLST (a) and CRISPR data (b) show that Choleraesuis, Paratyphi C and
Typhisuis share a common ancestor, whereas Decatur is made up of at least five unrelated populations. The numbers in panel ‘‘a’’ correspond to the
allelic difference between STs. The size of the circle is not correlated with the number of strains with the corresponding ST. The exact name of the
spacers and the spacer content of Decatur strains from panel b can be found in Table S2.
doi:10.1371/journal.pone.0036995.g002
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method for the real-time subtyping of serotype Typhimurium and
its monophasic variant. Based on the 83 CRISPR1-CRISPR2
combined alleles identified above, we developed a bead-based
liquid hybridization assay (LuminexH technology), CRISPOL (for
CRISPR polymorphism; Figure 4). A 25 to 32 bp capture probe
was designed for each of 72 of the 79 spacers identified (Table 6; it
was not possible to distinguish between some of the remaining
seven spacers by this approach. For example, STMB8var1 has a
single SNP located in position 1 of the spacer). Each capture probe
was coupled to a defined xMAP bead. We used thermolysates as
the DNA template and a single primer pair (including a
biotinylated primer) hybridizing to DR sequences to amplify the
spacer content of the two CRISPR loci rapidly. The PCR mixture
was hybridized with the 72 probe-coupled beads and incubated
with streptavidin-phycoerythrin for detection. The LuminexH
platform was then used to measure the fluorescence associated
with each bead (corresponding to a unique probe/spacer). This
method gave a highly robust readout, with mean fluorescence
signals of 709 to 5,707 in the presence of the spacer, and of 52 to
193 in the absence of the spacer (Table 7). The positive/negative
ratios were between 13 (for a bead for which coupling was not
optimal) and 92 (mean of 50.8). It was also easy to identify the four
SNP-variant spacers (Table 8). One probe, pSTMB26 had a
trimodal distribution, due to an intermediate population (MFI
between 300 and 1,200), whereas the positive population had an
MFI of more than 3,500. This intermediate population (consisting
mostly of emerging European monophasic isolates) contained
spacer STMB34, which is partly complementary to pSTMB26.
We designed a new probe targeting the other side of spacer
STMB26, but this probe was also partly complementary to
another spacer, STM28. We resolved this problem by subtracting
the value for the control strain 02-7015 (STMB34 positive) from
that for probe pSTMB26 in each experiment.
The repeatability of the CRISPOL assay was assessed by
running 30 isolates in triplicate and was high (data for five strains
provided in Table S9), with low standard deviations. The assay
was also highly reproducible, based on the results for the four
control strains (which, together, contained all the known spacers)
analyzed in each experiment. A cutoff of five times the value for
the background sample (consisting of all reaction components
except template DNA, which was replaced with water), which had
an MFI of approximately 300, was used to determine whether the
result was positive or negative for a given spacer. The distribution
of crude MFI values in a typical experiment with 65 isolates
showed the clear-cut distinction between negative and positive
results for spacers (Figure S2).
The concordance of the CRISPOL assay and sequencing results
was 100% for the spacer content of the 150 sequenced isolates.
Despite the presence of some genetic variation, such as duplica-
tions of spacers, VNTR variation of STM18 and the appearance
of SNP variants, which might result in spacers being missed by the
CRISPOL assay, no such effect was observed in practice as we
found no isolates with identical CTs but with alleles with different
sequences.
This method has two major advantages: its rapidity and low
cost. It requires 5.5 hours in total, with 2.75 hours of hands-on
time, to test 65 isolates from bacterial colonies, at an estimated cost
of J4 per sample for reagents and consumables.
The application of this method to almost 2,000 serotype
Typhimurium and monophasic variant isolates led to the
identification of 245 different CRISPOL types (CTs; Figure 5).
CT21 and its variants were strongly associated with the MDR
DT104 serotype Typhimurium clone (MLST type ST19).
Similarly, CT1 and its variants were strongly associated with the
emerging European monophasic 1,4,[5],12:i:- variant (MLST type
ST34). In total, 1,084 isolates (one per patient) were received at the
French National Reference Center for Salmonella (FNRC-Salm)
between January 1and July 4 2010; 89 CTs were observed among
the serotype Typhimurium isolates (n=677). The two most
prevalent types were CT21 (33% of isolates) and CT30 (11.5%);
both were associated with the DT104 clone. For monophasic
isolates (n=407), we identified 39 CTs, of which CT1 (50%) and
CT9 (14.7%) were the most prevalent. During this period a steady
increase in the prevalence of CT1 and three peaks of CT21,
CT136 and CT62 (two of which corresponded to documented
outbreaks) [36] were observed (Figure 6).
Application 3: Development of PCR assays targeting
specific serotypes or particular strains. The presence of
unique, constant spacers in certain serotypes, such as Typhi and
Paratyphi A, should make it possible to develop PCR assays
specific for these serotypes. As a proof-of-principle, we have
successfully developed and validated such PCRs for serotypes
Typhi and Paratyphi A (manuscript in preparation). Moreover, it
would be possible to develop a PCR assay for the detection of any
strain of interest with a particular spacer content provided that a
culture of this strain was available. For strains with no specific
spacers (common spacers only), we can use other stable
characteristics of the strain, such as the absence of a spacer-DR
unit between STM06 and STM24 (e.g., a MDR serotype
Typhimurium DT104 strain), to design primers yielding a PCR
product of known size.
Discussion
We demonstrate here that the assessment of CRISPR spacer
content is a robust, highly discriminatory and practical method for
typing Salmonella isolates. Serotyping has been the reference
method for Salmonella typing for almost 80 years. However, this
technique has a number of drawbacks, including low throughput,
high costs due to the need for highly trained staff and expensive
antisera, and accreditation problems. It is also of limited value for
Figure 3. CRISPR sizing by PCR for the rapid comparison of
Salmonella spp isolates. Results of PCR amplification for 8 S. enterica
serotype Typhimurium isolates collected from the same city during a
single week (cluster E in Table S7). Three cases were from the same food
poisoning cluster (the food isolate was also tested), whereas the other
cases were unrelated.
doi:10.1371/journal.pone.0036995.g003
CRISPR Polymorphisms in Salmonella
PLoS ONE | www.plosone.org 10 May 2012 | Volume 7 | Issue 5 | e36995strain discrimination, given the overdominance of a small number
of serotypes. There is therefore a clear need for improved methods
[37].
Recently developed ‘‘molecular serotyping’’ methods have been
proposed as an alternative. These methods mimic serotyping in
that they target the genes involved in biosynthesis of the flagellar
(fliC and fljB) [38] and/or the O-polysaccharide (encoded by the
rfb locus) antigens [2]. However, due to the complexity of the rfb
locus (8 to 23 kb, including more than 10 open reading frames), it
is currently possible to identify only a minority of the 46 O
serogroups of Salmonella by PCR. These approaches are also
subject to all the limitations inherent to serotyping in terms of a
lack of discrimination and a lack of polyphyletic group recognition.
MLST is a promising method for defining evolutionarily and
epidemiologically meaningful groups of Salmonella. A publicly
accessible database (http://mlst.ucc.ie/mlst/dbs/Senterica) in-
cludes data for more than 4,250 isolates from more than 500
serotypes [39]. Analyses of these data have revealed that most
serotypes are probably polyphyletic and therefore do not
correspond to natural groups descended from a single ancestor
and sharing important host association or virulence features. This
recent study highlights the importance of using phylogenetically
informative methods recognizing natural groups rather than
serotypes. However, MLST has a low discriminatory power and
is not suitable for the detection or investigation of outbreaks due to
highly prevalent monophyletic serotypes.
The data presented here for a global collection of 783 reference
strains and isolates from 130 serotypes of Salmonella, including the
most common serotypes involved in human infections, show a high
degree of CRISPR polymorphism. This polymorphism makes it
possible to distinguish between most serotypes and between MLST
groups within polyphyletic serotypes. Furthermore, microvaria-
tions, such as the loss, acquisition, duplication of spacers or point
mutations within spacers, have a strain discrimination capacity
similar to that of current gold standard methods, such as PFGE.
The CRISPR method can therefore be used for simultaneous
typing – defined as the determination of serotype or MLST group
– and subtyping. It therefore represents a single alternative to
several widely used reference methods: serotyping, PFGE and
phage typing. This genetic marker is based on polymorphic DNA
sequences of limited length, 0.5 to 3 kb. It therefore has major
advantages, in terms of analysis, throughput, standardization,
Figure 4. Overview of the bead-based CRISPOL assay for S. enterica serotype Typhimurium developed here. The estimated time for
each step is based on the testing of 65 isolates in a 96-well plate. The amplification step spans from the preparation of thermolysates to the gel
electrophoresis of PCR products.
doi:10.1371/journal.pone.0036995.g004
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CRISPR locus
Spacer name
(position) * Spacer DNA sequence (59–39){
Probe name
(position) **
1 STM01 (1) TTTTCAGCCCTTGTCGACTGCGGAACGCCCCT pSTM01 (1)
1 STM02 (2) GCGAAATAGTGGGGAAAAACCCCTGGTTAACC pSTM02 (2)
1 STM03 (3) TAGGCCTTGATACCATCGCTCGCACCTCGTCA pSTM03 (3)
1 STM03var1 (3) TAGGCCTTGATACCATCACTCGCACCTCGTCA pSTM03var1 (69)
1 STM03var2 (3) CAGGCCTTGATACCATCGCTCGCACCTCGTCA
1 STM25 (4) GTTTATTACTGCTTAGTTAATTAATGGGTTGC pSTM25 (4)
1 STM26 (5) AGGCGAATAATCTCTAATAGTCTCAATTCGTT pSTM26 (5)
1 STM27 (6) TAAATCTGGCGTCGAGACATTCGAAATAGTGC pSTM27 (6)
1 STM04 (7) TCTTTTGATTTTGCTGCGATGTTATAACCAGA pSTM04 (7)
1 STM05 (8) TATCCACATATACCCGCAATCATATTCAAGAA pSTM05 (8)
1 STM06 (9) AATCACTGCGGGGGTATTTAGCGGAAACGGCT pSTM06 (9)
1 STM07A (10) GATCGAGTAACGTGCGCTGGAACGCGTCGGCGCGGGGAACAC
1 STM07B (10) AATTAAAGCCGAGGGTGGCACCGCGCCTTATT pSTM07 (10)
1 STM07Bvar2 (10) AATTAAAGCCGAGGGTGGTACCGCGCCTTATT pSTM07var2 (70)
1 STM08 (11) GCACCTCGAAACGGTTTTAAAACACTACCGTTT pSTM08 (11)
1 STM09 (12) TGGACCGATGGGGCCAACATCGCCGAACGTGG pSTM09 (12)
1 STM10 (13) GTTACGTTCGGTAAATGGAAAGCGGCGAATAT pSTM10 (13)
1 STM11 (14) CCAGAAAGTGCCGGTAGTGCCTGATGAACGAC pSTM11 (14)
1 STM12 (15) CGCGCCCACTTCCGTAAAATACAGATAATCCA pSTM12 (15)
1 STM12var1 (15) CGCGCCCACTTCCGTAAGATACAGATAATCCA pSTM12var1 (71)
1 STM28 (16) GGCAGCGGGCGAGGCAAACACATTCGGGGCGT pSTM28 (16)
1 STM13 (17) GGTAATTTCTCATCTAACAGCCTGTACGCCTC pSTM13 (17)
1 STM14 (18) GAATCTAATGCAACAGATGAATAAACACGTAA pSTM14 (18)
1 STM15 (19) TCTTTATCGTCAATGCGAAATTTTCCGCGACG pSTM15 (19)
1 STM16 (20) TCCCATTCACCAACAACAATATCGCCCTGCAA pSTM16 (20)
1 STM17 (21) CGTTGCGTCAGGTTGATCCAGTGCGTCAGCGG pSTM17 (21)
1 STM18 (22) TCTCGGTCTCGGTCTCGGTCTCGGTAGTGACG pSTM18 (22)
1 STM18var1 (22) TCTCGGTCTCGGTCTCGGTCTCGGTCTCGGTCTCGGTCTCGGTAGTGACG
1 STM18var2 (22) TCTCGGTCTCGGTCTCGGTCTCGGTCTCGGTAGTGACG
1 STM18var3 (22) TCTCGGTCTCGGTCTCGGTAGTGACG
1 STM18var5 (22) TCTCGGTCTCGGTCTCGGTCTCGGTCTCGGTCTCGGTAGTGACG
1 STM19 (23) ACTTCCTTCAGTCTTAACGATAATCCGCAACG pSTM19 (23)
1 STM20 (24) GCAAAATAGCGATGAGCTGGCTACGCCCACTGG pSTM20 (24)
1 STM29 (25) AGCCGGCGCGAGCCTGGAGGGTTGAATAATGG pSTM29 (25)
1 STM30 (26) CAATCTCGCATTCGTTACCCCACCTGCATTTT pSTM30 (26)
1 STM21 (27) GAGGGGATAGGAGTTACGATCCAGCCTGGTTG pSTM21 (27)
1 STM22 (28) GTGGTTGCAGACCAATCAGCCCGCCAGCGGTT pSTM22 (28)
1 STM24 (29) CAGCACGAAAAATTATTTACTGTCGTTGCTCA pSTM24 (29)
1 STM31 (30) TGTAACAGTCCGTCGTTAATCAGCGCGGTGGG pSTM31 (30)
1 BraB14 (31) GAAGGTACGGGGAAAACAAAGATTACTCGTTC pBraB14 (31)
2 STMB0 (1) ATCTTCATATTGCGTGACGCTGCCGATGAACG pSTMB0 (32)
2 STMB32 (2) TCTTTATCAGCTAACCATTTCCAGAACTCGTC pSTMB32 (33)
2 STMB01 (3) TATAATATGAATTAATTTTTGCGCATAACCTG pSTMB01 (34)
2 STMB01var1 (3) TATAATATGAATTAATTTTTGCGTATAACCTG
2 STMB02 (4) TGCCCGTTCTGCCTCTTCGCACTCTCGATCAA pSTMB02 (35)
2 STMB03 (5) TGCGTAATGGGCTACCTGAACTTCACATATCC pSTMB03 (36)
2 STMB04 (6) ATTAAGCGCGCAAAGTTTGGGTTAATTGGACA pSTMB04 (37)
2 STMB05 (7) CGTATTCGTCACACAGCCCCGTCCAGAAATGA pSTMB05 (38)
2 STMB06 (8) TAACGAACTGAATAAAATGTCAGAAAGTGACG pSTMB06 (39)
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subtyping methods. We believe that this novel approach will
constitute a real improvement in the monitoring of Salmonella
infections, by making it possible to obtain results more rapidly,
thereby optimizing surveillance and outbreak detection.
We propose several different strategies for CRISPR genotyping
in Salmonella. First, determination of the sizes of the two CRISPR
loci by PCR can be used as an initial screen that is easy to
implement, even in low-capacity laboratories. This approach
requires no preliminary serotyping. Second, when more precise
discrimination is required, the spacer content can then be
investigated by Sanger sequencing of the PCR products, which
has the additional advantage of facilitating the detection of new
putative spacers. However, once the spacer diversity within a
serotype is known (i.e., after the analysis of a representative
collection of isolates of this serotype), higher throughput is
required for daily surveillance. We have developed a LuminexH-
based approach that is suitable for serotype Typhimurium, which
accounts for 50% of all cases of human salmonellosis in France
and is one of the two major serotypes worldwide. PFGE is
currently recommended for the real-time surveillance of this
serotype, but is technically demanding and poorly standardized in
many laboratories. It is therefore difficult to use PFGE in many
countries in which a single reference laboratory processes a large
number of isolates. The CRISPOL assay developed here covers
both serotype Typhimurium and its emerging monophasic variant.
It provides an excellent alternative to PFGE, being cheaper, less
technically demanding and yielding data that are easy to interpret
and exchange. An approach based on the initial use of the
CRISPOL assay, followed by MLVA for genetically homogeneous
populations, such as the DT104 clone (CT21) or the emerging
monophasic strain (CT1) would be highly effective. However, due
to limitations in the number of beads that can be mixed (500 for
the latest LuminexH platform), the universal use of a LuminexH-
based approach is not possible (the Salmonella serotypes analyzed to
date include 3,800 different spacers). Whole-genome sequencing
Table 6. Cont.
CRISPR locus
Spacer name
(position) * Spacer DNA sequence (59–39){
Probe name
(position) **
2 STMB07 (9) GCAGCTTAGCGACGAAATTAAAACCGAACTCAC pSTMB07 (40)
2 STMB08 (10) TGCCAGTGACTACAGAAGCGTCGCTATCGGGG pSTMB08 (41)
2 STMB08var1 (10) TGCCAGTGACTACAGAAGCGTCTCTATCGGGG pSTMB08var1 (72)
2 STMB09 (11) ACCGATAAACAACCGCATAGCCTCTTTCGTTT pSTMB09 (42)
2 STMB10 (12) TGCTCAATAACGTCGTAAATAGCGTAAGCTGG pSTMB10 (43)
2 STMB11 (13) TATTTCGCCTTCGGCACTGACGTCACCGTCAA pSTMB11 (44)
2 STMB12 (14) GTCGCGTTCGTTGCCGGTATAGACCAGCGTCA pSTMB12 (45)
2 STMB13 (15) ATCGAATCGAAACCCCAGCCACAGAAATAATT pSTMB13 (46)
2 STMB14 (16) GCTCATGTCAAACGCCATCAGCGTTCCGGCAT pSTMB14 (47)
2 STMB15 (17) AATCGCCAGCCTCGGAAATATTCCATCCTCCG pSTMB15 (48)
2 STMB16 (18) AGGAACTAAACAGCCTGACCGTTGAGGATCTG pSTMB16 (49)
2 STMB17 (19) ACCGGACAAATCTTTTTTTTCCTGTTCCTGTT pSTMB17 (50)
2 HadB20 (20) GGGCGGTCCCCGGCCTCAATACCGCGCTGACG pHadB20 (51)
2 STMB34 (21) TTGAGGTGCCGCTTGCCGTTCTTCTGTTTTTT pSTMB34 (52)
2 STMB18 (22) GGGCACTATGAACGGATCGGCGCTGATGCCGG pSTMB18 (53)
2 STMB19 (23) GGTAAAGCCACACCATTTTTTATTGACCTCGC pSTMB19 (54)
2 STMB33 (24) CTAGGAGGCGTAATGAATACTACGTATCAAAA pSTMB33 (55)
2 STMB20 (25) GTGGTGGCCTCAAATAAATTCGAGCGCTGGAG pSTMB20 (56)
2 STMB21 (26) TCGACGTGGACGAGGAGTTACTCAACCGCTGC pSTMB21 (57)
2 STMB22 (27) AGCGCCACATGGCCCACCGGCACCACCCGATC pSTMB22 (58)
2 STMB23 (28) AAATGACCAAATCAGAAATCTTCACCAAAGCC pSTMB23 (59)
2 STMB24 (29) TAATGGCCACAGTAAGTCAAACGGTTCTGGAA pSTMB24 (60)
2 STMB25 (30) GAGTCCGGGGGTTATATAGTTATTTAATGAGC pSTMB25 (61)
2 STMB26 (31) TTGGGCGTCGGTTTTTTCAGGTTTAGGTCCGG pSTMB26 (62)
2 STMB27 (32) TCAACTGTCAGTTCGTCGTTAGCCAGTAATTC pSTMB27 (63)
2 STMB28 (33) CTGAAAACGCATGGAATCCGGTATAAACAGTC pSTMB28 (64)
2 STMB29 (34) GATGTAACTGATAGCGAAATATATTGGGATAA pSTMB29 (65)
2 STMB30 (35) GAAACGTAAACAGGGTAAGATACAACTCTGCA pSTMB30 (66)
2 STMB31 (36) TGTAAAGGGTGGTCTGGAAGGGGATCGGCAAA pSTMB31 (67)
2 STMB35 (37) TCGTGTGAGGTCGCTGAGAAAAACGGGGCGTA pSTMB35 (68)
*position of the spacer within the CRISPR1 or CRISPR2 locus.
{single polymorphic nucleotides that define spacer variants are shown in bold typeface; probe sequences are underlined.
**position of the probe in the CRISPOL assay.
doi:10.1371/journal.pone.0036995.t006
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Probe name (bead no.)
Spacer absent
Median (MFI)±SD
1
Spacer present
Median (MFI)±SD Ratio
2 positive/negative
pBraB14 (29) 65610 38666570 59
pSTMB35 (30) 70614 35406445 51
pHadB20 (31) 6268 15446200 25
pSTM01 (32) 5369 25476332 48
pSTM02 (33) 81612 25866308 32
pSTM03 (34) 5664 380865394 68
pSTM03var1 (35) 5263 240965324 48
pSTM04 (36) 5768 41876390 73
pSTM05 (37) 173613 52166605 30
pSTM06 (38) 6464 30196337 47
pSTM07 (39) 66611 458064944 69
pSTM07var2 (40) 65613 328364714 54
pSTM08 (41) 55677 0 9 6154 13
pSTM09 (42) 68611 40656397 60
pSTM10 (43) 94617 40366402 43
pSTM11 (44) 6269 45646518 74
pSTM12 (45) 69611 334365154 46
pSTM12var1 (46) 6168 117362804 20
pSTM13 (47) 5867 38126539 66
pSTM14 (48) 5968 41836381 71
pSTM15 (49) 72614 34586452 48
pSTM16 (50) 71613 499061061 70
pSTM17 (51) 89615 20926333 24
pSTM18 (52) 79614 38636610 49
pSTM19 (53) 68615 33596289 49
pSTM20 (54) 6569 31136375 48
pSTM21 (55) 74614 41006573 56
pSTM22 (56) 7169 21586304 30
pSTM24 (57) 5066 46036440 92
pSTM25 (58) 60611 41786382 70
pSTM26 (59) 6267 47726521 78
pSTM27 (60) 59610 40616364 69
pSTM28 (61) 6169 41866328 69
pSTM29 (62) 6169 35086418 58
pSTM30 (63) 73611 45326670 62
pSTM31 (64) 68610 32096409 47
pSTMB0 (65) 55612 39526398 73
pSTMB01 (66) 64616 54096674 85
pSTMB02 (67) 65611 39876500 62
pSTMB03 (68) 5869 25086713 43
pSTMB04 (69) 68613 49136558 72
pSTMB05 (70) 6068 51966574 87
pSTMB06 (71) 6168 18026343 30
pSTMB07 (72) 62610 44476477 71
pSTMB08 (73) 69610 121064535 53
pSTMB08var1 (74) 69610 126662515 27
pSTMB09 (75) 6669 12666251 19
pSTMB10 (76) 6467 26296480 41
pSTMB11 (77) 5969 20366279 35
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can be decreased. WGS could be customized to focus exclusively
on the two CRISPR sequences. The known spacer sequences
would be extracted and compared with the contents of a
CRISPR/serotype database. Another alternative would involve
the use of a microarray approach based on DNA oligonucleotides
Table 7. Cont.
Probe name (bead no.)
Spacer absent
Median (MFI)±SD
1
Spacer present
Median (MFI)±SD Ratio
2 positive/negative
pSTMB12 (78) 73611 21476276 30
pSTMB13 (79) 69614 51426805 75
pSTMB14 (80) 6468 20346289 32
pSTMB15 (81) 67610 35246466 53
pSTMB16 (82) 78612 50626547 65
pSTMB17 (83) 94616 29476437 32
pSTMB18 (84) 80611 37456532 47
pSTMB19 (85) 101613 45706733 45
pSTMB20 (86) 75614 45736483 61
pSTMB21 (87) 73612 35566319 49
pSTMB22 (88) 84616 57076636 68
pSTMB23 (89) 6969 54346642 78
pSTMB24 (90) 7168 35256450 50
pSTMB25 (91) 72610 20396395 28
pSTMB26 (92) 19362443 35996664 19
pSTMB27 (93) 101615 34646505 34
pSTMB28 (94) 87612 32186391 37
pSTMB29 (95) 87613 35426519 41
pSTMB30 (96) 79610 38056442 48
pSTMB31 (97) 83615 21956304 27
pSTMB32 (98) 83612 48326551 58
pSTMB33 (99) 7068 21436249 30
pSTMB34 (100) 78611 31096513 40
1MFI, median fluorescence intensity (raw data); SD, standard deviation.
2The ratio is the positive average median fluorescence intensity (MFI) divided by the negative average MFI.
3Due to partial identity with spacer STMB34, the signal of pSTMB26 is stronger in isolates containing spacer STMB34 (such as the emergent monophasic population).
This has been taken into account by subtracting the MFI of control strain #02-7015 from that of pSTMB26 in each experiment. The corrected median is 183646 with a
ratio of 20.
4Median calculated for 24 isolates.
5Median calculated for 20 isolates.
doi:10.1371/journal.pone.0036995.t007
Table 8. Probe responses in the CRISPOL assay for SNP variants (individual isolates).
Probe name (bead no.)
Isolate #81-299 (STM03 variant
1) Median (MFI)±SD
Isolate #DK4 (STM07
variant 2) Median
(MFI)±SD
Isolate #02-277 (STM12 variant 1)
Median (MFI)±SD
Isolates #02-3369, #02-7105,
#01-1639, #81-482, #81-831
(STMB08 variant 1) Median
(MFI)±SD
pSTM03 (34) 3807689 NA NA NA
pSTM03var1 (35) 45736132 NA NA NA
pSTM07 (39) NA 1944641 NA NA
pSTM07var2 (40) NA 51436140 NA NA
pSTM12 (45) NA NA 1493661 NA
pSTM12var1 (46) NA NA 4146685 NA
pSTMB08 (73) NA NA NA 22046328
pSTMB08var1 (74) NA NA NA 42776420
Results in triplicate; MFI, median fluorescence intensity (raw data); SD, standard deviation; NA: not applicable.
doi:10.1371/journal.pone.0036995.t008
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Typhimurium or its monophasic variant of antigenic formula 1,4,[5],12:i:-. Black squares indicate presence of the spacer, as detected by the
corresponding probe, whereas white indicates an absence of the spacer. For the determination of CRISPOL types (CTs), each of the 68 spacers was
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subtyping applications remain to be developed for the most
epidemiologically important serotypes or MLST groups, such as
Enteritidis and Newport. For this purpose, it should be straight-
forward to apply the strategy presented here for serotype
Typhimurium.
Clearly, there is also a need to extend the serotype coverage of
the spacer content inventory, as only the 130 most important
serotypes have been investigated so far. We hope to capture all the
diversity of Salmonella (.2,500 serotypes) in the next 10 years, and
the CRISPR/serotype dictionary available from our open-access
website will be updated accordingly. This web tool can be used to
extract and identify spacers from a submitted DNA sequence and
for comparisons with a well curated database (i.e., containing
accurately serotyped isolates). The application of this tool to
CRISPR sequences identified as corresponding to Enteritidis
isolates by Liu et al. [27], showed that 10 of the 27 considered
actually corresponded to Typhimurium (EST21, EST22), Infantis
(EST17), Kentucky (EST23), and Heidelberg (EST15), rather than
Enteritidis. All these discrepancies related to isolates obtained from
a local diagnostic laboratory and not from the reference laboratory
participating in the study, which suggests that serotyping errors
were the cause.
In conclusion, we have demonstrated that CRISPR is a
powerful method suitable for use in the molecular typing and
subtyping of Salmonella isolates. We believe that, given its combined
advantages, CRISPR strain characterization is an excellent
potential alternative to both serotyping and PFGE, the current
gold standard methods. Given the rapidity of this method, in
particular, it should have a major impact on surveillance and
outbreak investigation and is likely to be of benefit to public health.
Materials and Methods
Salmonella Strains and Isolates
In the first part of this study (spacer content inventory and
comparison with current typing and subtyping methods), we used
744 Salmonella reference strains or isolates belonging to 130
serotypes (including those most frequently identified in human and
food products). These serotypes belonged to two species of the
Salmonella genus: S. enterica and S. bongori and the six subspecies of S.
enterica: enterica, salamae, arizonae, diarizonae, indica and houtenae
(Tables S2 and S4). The Salmonella serotype reference strains were
obtained from the World Health Organization Collaborative
Center for Reference and Research on Salmonella (WHOCC-
Salm). Most of the isolates were from the French National
Reference Center for Salmonella (FNRC-Salm). Both these centers
are located at the Institut Pasteur, Paris. Other strain and isolate
providers are acknowledged at the end of the manuscript. The
strains and isolates studied were obtained from around the world,
between 1885 and 2010. Larger subsets of isolates from prevalent
serotypes were assembled to reflect as accurately as possible the
diversity of these populations: Typhimurium or its monophasic
variant with antigenic formula 1,4,[5],12:i:- (n=150), Enteritidis
(n=187), polyphyletic serotypes such as Newport (n=21) and
Paratyphi B (n=36), and serotypes with the antigenic formula
6,7:c:1,5 (n=34), or clinically important serotypes, such as Typhi
(n=20) and Paratyphi A (n=14). This test population was
generally well defined in terms of its epidemiological context,
treated as a numerical character indicating absence (0) or presence (1 for all spacers except BraB14, for which an arbitrary value of 10 was assigned) in
BioNumerics 6.5 software (Applied Maths, Sint-Martens-Latem, Belgium). Similarities between CTs were assessed by calculating the Pearson product-
moment, and a dendrogram was constructed by the unweighted pair group method with arithmetic mean (UPGMA). The four SNP-variant spacers
targeted by probes 69 to 72 are shown but were excluded from the phylogenetic analysis, as they were not independent. A indicates a group of
profiles derived from CT1, the main type of emerging monophasic isolates. B indicates a group of profiles derived from CT21, which is associated with
multidrug-resistant DT104 serotype Typhimurium isolates. C indicates a group of serotype Typhimurium isolates of ST36 that may have one or two
specific spacers on the leader side of CRISPR1 (BraB14) and CRISPR2 (STMB35).
doi:10.1371/journal.pone.0036995.g005
Figure 6. Distribution of selected CRISPOL types of S. enterica serotype Typhimurium and S. enterica with antigenic formula
1,4,[5],12:i :- isolated from humans in France between January 1 and July 4 2010. Over this period, all 1,084 isolates (one per patient) were
CRISPOL-typed and two outbreaks were investigated. Outbreak A (<40 cases) was due to the consumption of a raw milk cheese contaminated with a
CT62 highly multidrug-resistant S. enterica serotype Typhimurium strain, whereas outbreak B (<50 cases) was caused by the consumption of a dried
pork sausage contaminated with a CT136 S. enterica 4,12:i:- strain. The third peak, corresponding to CT21, in May was neither detected nor
investigated, as CRISPOL typing was carried out retrospectively.
doi:10.1371/journal.pone.0036995.g006
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MLVA type, haplotype and MLST type, as determined by
methods described elsewhere [9,32,33,40,41].
In the second part of the study, we validated the CRISPOL
method on 150 serotype Typhimurium or 1,4,[5],12:i:- isolates for
which both CRISPR loci were sequenced. The method was then
applied to a collection of 1,900 isolates from the WHOCC-Salm
and from the FNRC-Salm, including all isolates received by the
FNRC-Salm from January 1 2010 to July 4 2010 (n=1,131
isolates from 1,084 patients).
Inventory of the Spacer Content of 744 Salmonella
Strains and Isolates and 39 Genomes of 130 Serotypes
In silico analysis. We analyzed CRISPR spacer content in
39 full genome sequences of S. enterica and S. bongori (Table 1).
Regions containing CRISPR sequences were identified by a blast
(ncbi) search of the 29 bp DR consensus sequence of S. enterica
serotype Typhi strain Ty2 (59-
CGGTTTATCCCCGCTGGCGCGGGGAACAC-39) [14]. Re-
gions downstream from the iap gene and upstream from the ygcF
gene were downloaded and the spacer-DR units of each CRISPR
locus were extracted manually.
DNA extraction. Total DNA was extracted with the
InstaGene matrix (BioRad, Marnes la Coquette, France) or the
Wizard kit (Promega, Madison, WI, USA) in accordance with the
manufacturer’s recommendations.
PCR and sequencing of the CRISPR1 and CRISPR2
loci. Oligonucleotide primers for amplification of the CRISPR1
and CRISPR2 loci from all Salmonella spp. were designed on the
basis of consensus alignments of the available Salmonella genomes
(Tables 1 and 2). The CRISPR1 locus was amplified with the
forward A1 primer (binding 74 bp upstream from the CRISPR1
of serotype Typhimurium strain LT2) and the reverse primer A2
(binding 130 bp downstream). Alternative reverse primers, such as
A3 to A7, were required for some isolates. The CRISPR2 locus
was amplified with the forward primer B1 (binding 110 bp
upstream from CRISPR2) and the reverse primers B2 and B3
(binding 45 bp and 324 bp downstream from the CRISPR2 locus
of strain LT2, respectively). The B3 primer was designed because
no region homologous to B2 was found in subsp. diarizonae. The
primers were synthesized by MWG-Biotech (Ebersberg, Ger-
many). Single-locus amplifications were performed in a total
volume of 50 ml containing DNA (2.5 ml from InstaGene matrix or
2 ml diluted 10-fold from Wizard), primers (10 pmol each),
deoxynucleoside triphosphate (100 mM), Taq DNA polymerase
(0.85 U of GoTaq Flexi DNA polymerase; Promega) and its buffer,
MgCl2 (1.5 mM) and dimethylsulfoxide (5%). The cycling
conditions were as follows: 2 min for denaturation at 94uC( 1
cycle), followed by 35 cycles of 1 min at 94uC for denaturation,
1 min at 59uC (61uC when using the A1-A4 pair) for annealing,
and 90 s at 72uC for polymerization, followed by an additional
10 min at 72uC for extension.
The entire region spanning both CRISPR loci was amplified
with primers A1 and B3. For this purpose, DNA was extracted
with the Promega Wizard kit and PCR was carried out with the
Expand Long Template PCR System kit (Roche).
Both strands of purified amplicons were sequenced with Big
Dye Terminator version 3.1 (Applied Biosystems, Foster City, CA)
on an ABI 3730XL apparatus (Applied Biosystems).
BioNumerics 6.5 software (Applied Maths, Sint-Martens-Latem,
Belgium) was used to analyze nucleotide sequences.
Development of Web-accessible Tools and CRISPR/
serotype Dictionary
We have developed a web tool for the creation and storage of
catalogues of spacers and DR variants. This ‘‘Institut Pasteur
CRISPR database for Salmonella’’ can be queried online at http://
www.pasteur.fr/recherche/genopole/PF8/crispr/CRISPRDB.
html. The content of the catalogue is used to identify known
spacers and DRs in a submitted DNA sequence, which is coded
into a succession of DR and spacer identifiers by the query
‘‘Search spacers composition for query’’. If part of the
sequence has no exact matches in the DR and spacers dictionary,
a blast query can then be used to obtain the nearest match (‘‘Blast
unknown spacer sequence against dictionary’’), to identify
new spacers or new DR variants. Isolates analyzed at the FNRC-
Salm and coded as spacer-DR arrays within the CRISPR/
serotype dictionary can be downloaded with the ‘‘Browse
spacers composition for the published strains’’ query. .
Spacer nomenclature. The spacer names start with a three-
to four-letter prefix indicating the serotype from which the spacer
was extracted for the first time. The suffix B indicates spacers
found in the CRISPR2 locus. Spacers were numbered consecu-
tively in order of discovery. The start of spacer arrays is described,
starting downstream from the iap gene. SNP or VNTR variants
are denoted as ‘‘var’’ (e.g., EntB0var1, STM18var2).
Calculation of discrimination indices. The discriminatory
abilities of the CRISPR, PFGE and phage typing methods were
assessed by calculating Simpson’s index of diversity (D value), as
previously described [42].
Statistic analysis. The mean number and standard devia-
tion of the spacers in the CRISPR loci were calculated with Excel
(Microsoft).
Nucleotide sequence accession numbers. The nucleotide
sequences of the CRISPR loci have been assigned GenBank
accession numbers JF724159 to JF725640.
Development of a High-throughput Subtyping Method
(CRISPOL) for Serotype Typhimurium
DNA extraction. We increased the throughput of this
method by using thermolysates as the DNA template. Briefly, we
suspended a 10 ml loop of bacteria in 200 ml of molecular biology-
grade water. The suspension was vortexed for 10s, incubated at
95uC for 10 min and then centrifuged for 5 minutes at 13000 rpm
in a Jouan A14 centrifuge. The supernatant was transferred to a
1.5 ml microtube and stored at 220uC until use.
PCR amplification. We followed the strategy used for
Mycobacterium spoligotyping, based on the use of two primers
hybridizing to the DRs in opposite directions, one of which was 59-
biotinylated [17]. The primers were DRSTMA (59-
CCGCTGGCGCGGGGAACA-39) and DRSTMB (59Biot-
CGCCAGCGGGGATAAACC-39). Amplifications were carried
out in a volume of 50 ml containing 1 ml of thermolysate (or 1 mlo f
molecular biology-grade water for the blank), primers (50 pmol
each), deoxynucleoside triphosphate (200 mM), Taq DNA poly-
merase (0.85 U of Go Taq; Promega) and its buffer, MgCl2
(1.5 mM). The cycling conditions were as follows: 2 min at 95uC
for initial denaturation, followed by 20 cycles of 1 min at 95uC for
denaturation, 30 s at 59uC for annealing and 15 s at 72uC for
polymerization. The PCR products were checked by electropho-
resis in 1.2% agarose gels and were stored at 220uC for no more
than three days before use in the LuminexH assay.
Probes and microbead coupling. We designed 72 spacer-
derived oligonucleotide probes (including four SNP-variant
probes) of between 25 and 32 nucleotides in size (Table 6). These
probes were synthesized by Eurogentec (Angers, France), with a 59
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linker. The 72 Luminex xMap microbeads (L100-C129 to L100-
C200) were coupled to the 72 probes, as previously described [43].
Each type of coupled microbead was resuspended in 1 6 TE
(10 mM Tris, 1 mM EDTA, pH 8) at a final concentration of
approximately 50,000 microbeads per ml. We then combined
equal volumes of each type of coupled microbead in Protein
LoBind tubes (Eppendorf, Hamburg, Germany). The mixture was
stored in the dark at 4uC before and after use.
Hybridization. Hybridization was performed in a polycar-
bonate plate with 96 conical wells (Corning, Corning, NY, USA), to
which we added 10 ml of PCR product, 7 mlo f16TE and 33 mlo f
probe-coupled microbeads diluted in 1.5 6 TMAC buffer (5 M
tetramethyl ammonium chloride [Sigma, St. Louis, MO, USA],
20% Sarkosyl, 1 M Tris-HCl [pH 8.0], 0.5 M EDTA [pH 8.0]) to
a final concentration of approximately 75 microbeads per ml for
each type of coupled microbead. The plates were sealed with
adhesive PCR film (ABgene, Epsom, UK) and heated to 94uC for
3 min for initial denaturation, followed by hybridization at 59uC for
20 min. The plate was centrifuged at 4,000 g for 3 min and the
supernatant was carefully discarded. A reporter mix consisting of
90 ml of streptavidin-R-phycoerythrin (1.25 mg/ml in 1 6TMAC;
Invitrogen, Carlsbad, CA, USA) was added to each well and the
microbead pellet was resuspended. The microplate was then
incubated for 5 minutes and analyzed on the LuminexH platform.
Analysis on the Luminex platform. The microplate was
analyzed in a LuminexH 200 system at a temperature of 50uC.
Analyses were based on counts for 50 beads per set.
Data analysis. Four strains (SARA8, 81-784, 02-7015 and
07-1777) with a known spacer content covering all the spacers in
the assay and a blank (in which DNA was replaced with water)
were analyzed in each experiment. For all probes except
pSTMB26, relative fluorescence unit values were corrected by
subtracting the value for the blank. In the case of negative
corrected values, an arbitrary value of 25 was attributed. For
STMB26, values were corrected by subtracting those for 07-1777,
due to a weak cross-reaction observed in emerging monophasic
variant strains (07-1777 being a monophasic variant isolate). A
cutoff value five times higher than the corrected value was defined.
For pSTM03, pSTM07, pSTM12 and pSTMB9 probes and their
SNP variant probes pSTM03var1, pSTM07var2, pSTM12var1,
and pSTMB9var1, assignment to the wild-type spacer or its SNP
variant was based on the ratio of crude values for each probe. If
the wild-type probe/SNP variant probe ratio was .1.1, then the
wild-type spacer was attributed to the isolate. If the wild-type
probe/SNP variant probe ratio was ,0.9, then the SNP variant
spacer was attributed to the isolate. An R tool was developed to
automate the analysis. For each strain an allelic pattern, referred
to as the CRISPOL type (CT), consisting of the presence or
absence of the 68 ordered CRISPR1, then CRISPR2 probes,
followed by the four SNP-variant probes, was generated. Data
were incorporated into a dedicated CRISPOL database with
BioNumericsH software. A provisional number was assigned to
each strain with a new CT, (e.g., CT62prov) until both CRISPR
regions had been sequenced, to check for consistency with the CT
and for an absence of new spacers.
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